1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment
  6. Apixaban (Eliquis)

Apixaban (Eliquis)

91 - 105 of 106 Results
Sort Results:
Other: Managing Antithrombotics Before Minor Procedures May 2013
Commentary: Managing Antithrombotics Before Minor Procedures May 2013
Article: whether it's okay to use the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) for "off-label" indications April 2013
PL Voices: “Off-Label” Uses of the New Oral Anticoagulants April 2013
Chart: Off-Label Use of the Newer Anticoagulants April 2013
Article: approval of Eliquis (ELL-eh-kwiss, apixaban) will intensify the marketing war among the NEW oral anticoagulants February 2013
PL Voices: Comparing the New Oral Anticoagulants February 2013
Article: when it makes sense to take MORE than 81 mg/day of aspirin to prevent cardiovascular events September 2012
Guideline: 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction September 2012
PL Voices: Debate over Aspirin Dose to Prevent Cardiovascular Events September 2012
Guideline: 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention September 2012
Article: new debate about which anticoagulant is best to prevent strokes in atrial fib patients March 2012
Commentary: Dabigatran and Risk of Myocardial Infarction March 2012
PL Voices: Does Pradaxa (dabigatran) Increase Heart Attack Risk? March 2012
Article: controversy over which ORAL anticoagulant to use to prevent strokes in patients with atrial fibrillation October 2011